Fecal microbiota transplant (FMT)
Fecal microbiota transplant (FMT) is a pharmaceutical drug with 17 clinical trials. Currently 5 active trials ongoing. Historical success rate of 77.8%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
5
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease
Clinical Trials (17)
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease
Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
A Study of FMT in Patients With AML Allo HSCT in Recipients
Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus
FMT for MDRO Colonization After Infection in Renal Transplant Recipients
Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis
Fecal Transplant for Crohn's Disease
Epigenetic and Microbiota Modifications
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy
Early FMT for C.Difficile
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17